DAVITA INC. Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
DAVITA INC. (DVA) reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $358.20 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-21.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2014-02-21
- DAVITA INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2013 was $358.20M, a 0.00% change from fiscal 2012.
- DAVITA INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2012 was $358.20M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month |
|---|---|
| 2013-12-31 | $358.20M 10-K · filed 2014-02-21 |
| 2012-12-31 | $358.20M 10-K · filed 2013-03-01 |
| 2011-12-31 | $358.20M 8-K · filed 2012-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |